AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimcas 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Medicasa Pharmaceutical

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimcas 1mg/500mg Tablet SR

Diabetic patients using Glimepiride/Metformin 1mg/500mg extended-release tablets should be aware that this medication, an anti-diabetic combination therapy, helps manage blood glucose levels in type 2 diabetes. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; abrupt cessation can lead to dangerously elevated blood sugar, increasing the risk of complications like kidney failure, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight control as directed by your healthcare provider. Hypoglycemia (low blood sugar) is a common side effect, characterized by symptoms such as sweating, dizziness, headaches, and tremors. Prompt treatment with fast-acting glucose, such as sugary snacks or juice, is necessary. Regular meals and carrying a readily available glucose source are essential preventative measures. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Those with a history of cardiovascular disease should consult their physician prior to commencing treatment. Pregnant or lactating women should seek medical advice before using this medication. Regular blood sugar monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.

Primary Ingredients of Glimcas 1mg/500mg Tablet SR

The provided text is "undefined," therefore, no rephrasing is possible.

Uses of Glimcas 1mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glimcas 1mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimcas 1mg/500mg Tablet SR whole; do not crush, chew, or divide it. Administer this medication with food.

Common Side effects of Glimcas 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimcas 1mg/500mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or dividing it. The Glimcas 1mg/500mg Extended-Release tablet should be taken with a meal.

How Glimcas 1mg/500mg Tablet SR works:

Glimcas SR tablets (1mg/500mg) contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts through multiple mechanisms: decreasing liver glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Avoid alcohol while taking Glimcas 1mg/500mg SR tablets.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimcas 1mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Medical advice is recommended.

Breast feedingBreast feedingUNSAFE

Extended-release Glimcas tablets (1mg/500mg) are contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimcas 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. Glimcas 1mg/500mg SR tablets are contraindicated in those with severe kidney disease. Regular monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Glimcas 1mg/500mg Tablet SR cautiously, as dose modification may be necessary. A physician's consultation is advised. For patients experiencing mild to moderate liver disease, Glimcas 1mg/500mg Tablet SR is typically initiated at a low dosage; however, its use is contraindicated in cases of severe liver dysfunction.

What if you forget to take Glimcas 1mg/500mg Tablet SR :

Should you forget to take your Glimcas 1mg/500mg SR tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimcas 1mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimcas 1mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication. Keep it out of reach of children, pets, and others.
Glimcas 1mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). While rare, this harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Glimcas 1mg/500mg Tablet SR and seek immediate medical attention.
Glimcas 1mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 diabetes.
Glimcas 1mg/500mg Tablet SR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Glimcas 1mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended annually by some researchers.
Glimcas 1mg/500mg Tablet SR can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases with missed or delayed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimcas 1mg/500mg SR tablets with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glimcas 1mg/500mg Tablet ...
44
MRP 53
16% off